These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22034480)

  • 1. Treatment of chronic heart failure with β-adrenergic receptor antagonists: a convergence of receptor pharmacology and clinical cardiology.
    Bristow MR
    Circ Res; 2011 Oct; 109(10):1176-94. PubMed ID: 22034480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of β-adrenergic receptor antagonists for the treatment of heart failure: a paradigm for translational science.
    Feldman AM
    Circ Res; 2011 Oct; 109(10):1173-5. PubMed ID: 22034479
    [No Abstract]   [Full Text] [Related]  

  • 3. [Beta-adrenergic receptor blockers in clinical practice].
    Czuriga I; Edes I
    Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta-adrenoceptor antagonists in the treatment of chronic heart failure].
    Bundkirchen A; Brixius K; Schwinger RH
    Pharmazie; 2004 Feb; 59(2):83-92. PubMed ID: 15025174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The therapy of chronic heart failure with beta-receptor blockers?].
    Schwinger RH; Böhm M; Erdmann E
    Dtsch Med Wochenschr; 1990 May; 115(21):825-31. PubMed ID: 1971212
    [No Abstract]   [Full Text] [Related]  

  • 6. [Addition of beta blockers in chronic heart failure].
    Missault LH; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2000 Sep; 144(40):1905-10. PubMed ID: 11045137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-adrenergic receptor subtype signaling in the heart: from bench to the bedside.
    Zhu W; Woo AY; Zhang Y; Cao CM; Xiao RP
    Curr Top Membr; 2011; 67():191-204. PubMed ID: 21771491
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-adrenergic blocking agents in congestive heart failure.
    Goldstein S
    Henry Ford Hosp Med J; 1986; 34(3):184-7. PubMed ID: 2879814
    [No Abstract]   [Full Text] [Related]  

  • 9. What is the role of beta-adrenergic signaling in heart failure?
    Lohse MJ; Engelhardt S; Eschenhagen T
    Circ Res; 2003 Nov; 93(10):896-906. PubMed ID: 14615493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
    Yokota Y
    J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential novel pharmacological therapies for myocardial remodelling.
    Landmesser U; Wollert KC; Drexler H
    Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beta-adrenergic receptor blockers in the treatment of chronic heart failure].
    Mularek-Kubzdela T; Grajek S; Cieśliński A
    Pol Merkur Lekarski; 1996 Aug; 1(2):120-3. PubMed ID: 9156910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenergic receptor blockers as therapy in pediatric chronic heart failure.
    Shaddy RE
    Minerva Pediatr; 2001 Aug; 53(4):297-304. PubMed ID: 11573066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nebivolol in chronic heart failure: current evidence and future perspectives.
    Lipsic E; van Veldhuisen DJ
    Expert Opin Pharmacother; 2010 Apr; 11(6):983-92. PubMed ID: 20307222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure.
    Port JD; Bristow MR
    J Mol Cell Cardiol; 2001 May; 33(5):887-905. PubMed ID: 11343413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular restoration of beta-adrenergic receptor signaling improves contractile function of failing hearts.
    Tevaearai HT; Koch WJ
    Trends Cardiovasc Med; 2004 Aug; 14(6):252-6. PubMed ID: 15451518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic and clinical rationales for using beta-blockers in heart failure.
    Bristow MR
    J Card Fail; 2000 Jun; 6(2 Suppl 1):8-14. PubMed ID: 10908093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cellular and physiologic effects of beta blockers in heart failure.
    Sabbah HN
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with beta-adrenergic receptor antagonists and phosphodiesterase inhibitors for chronic heart failure.
    Van Tassell BW; Radwanski P; Movsesian M; Munger MA
    Pharmacotherapy; 2008 Dec; 28(12):1523-30. PubMed ID: 19025433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.
    Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Gheorghiade M; Inge PJ; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Circ Heart Fail; 2010 Sep; 3(5):596-605. PubMed ID: 20634483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.